Breast surgery outcomes as quality measures according to the NSQIP database

Annals of Surgical Oncology

Volumn 19, Issue 10, 2012, Pages 3212-3217

  Eck, Dustin L ^a   Koonce, Stephanie L ^a   Goldberg, Ross F ^a   Bagaria, Sanjay ^a   Gibson, Tammeza ^a   Bowers, Steven P ^a   McLaughlin, Sarah A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST SURGERY; BREAST TUMOR; CANCER SURGERY; COHORT ANALYSIS; GENERAL SURGERY; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MORBIDITY; OUTCOMES RESEARCH; PARTIAL MASTECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; QUALITY CONTROL; SURGICAL PATIENT; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; WOUND INFECTION;

BENCHMARKING; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; QUALITY ASSURANCE, HEALTH CARE; QUALITY IMPROVEMENT; QUALITY OF HEALTH CARE; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 84868205522     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2529-6     Document Type: Article

References (26)

1. Sigston E, de Mones E, Babin E, Hans S, Hartl DM, Clement P, et al. Early-stage glottic cancer: oncological results and margins in laser cordectomy. Arch Otolaryngol Head Neck Surg. 2006;132:147-52. (Pubitemid 43356250)
2. Ansarin M, Santoro L, Cattaneo A, Massaro M, Calabrese L, Giugliano G, et al. Laser surgery for early glottic cancer: impact of margin status on local control and organ preservation. Arch Otolaryngol Head Neck Surg. 2009;135(4):385-290.
3. Daley J, Forbes MG, Young GJ, Charns MP, Gibbs JO, Hur K, et al. Validating risk-A djusted surgical outcomes: site visit assessment of process and structure. National VA Surgical Risk Study. J Am Coll Surg. 1997;185(4):341-51. (Pubitemid 27419191)
4. Gibbs J, Clark K, Khuri S, Henderson W, Hur K, Daley J. Validating risk-A djusted surgical outcomes: chart review of process of care. Int J Qual Health Care. 2001;13(3):187-96. (Pubitemid 32677170)
5. Schnitt SJ. Risk factors for local recurrence in patients with invasive breast cancer and negative surgical margins of excision. Where are we and where are we going? Am J Clin Pathol. 2003;120(4):485-8. (Pubitemid 37186043)
6. Leong C, Boyages J, Jayasinghe UW, Bilous M, Ung O, Chua B, et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer. 2004;100(9):1823-32. (Pubitemid 38529559)
7. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233-41. (Pubitemid 35176242)
8. McKinney CD, Frierson HF Jr, Fechner RE, Wilhelm MC, Edge SB. Pathologic findings in nonpalpable invasive breast cancer. Am J Surg Pathol. 1992;16(1):33-6.
9. Wilhelm MC, Edge SB, Cole DD, deParedes E, Frierson HF Jr. Nonpalpable invasive breast cancer. Ann Surg. 1991;213(6):600- 3; discussion 3-5.
10. Gajdos C, Tartter PI, Bleiweiss IJ, Hermann G, de Csepel J, Estabrook A, et al. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics. Ann Surg. 2002;235(2):246-51. (Pubitemid 34111954)
11. Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon- Underwood S, et al. National Institutes of Health State-of-the- Science Conference statement: diagnosis and management of ductal carcinoma in situ, September 22-24, 2009. J Natl Cancer Inst. 2010;102(3):161-9.
12. NIH consensus conference. Treatment of early-stage breast cancer. JAMA. 1991;265(3):391-5.
13. Morrow M, White J, Moughan J, Owen J, Pajack T, Sylvester J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol. 2001;19(8):2254-62. (Pubitemid 32366978)
14. Parviz M, Cassel JB, Kaplan BJ, Karp SE, Neifeld JP, Penberthy LT, et al. Breast conservation therapy rates are no different in medically indigent versus insured patients with early stage breast cancer. J Surg Oncol. 2003;84(2):57-62. (Pubitemid 37247909)
15. McCahill LE, Privette A, James T, Sheehey-Jones J, Ratliff J, Majercik D, et al. Quality measures for breast cancer surgery: initial validation of feasibility and assessment of variation among surgeons. Arch Surg. 2009;144(5):455-62; discussion 62-3.
16. El-Tamer MB, Ward BM, Schifftner T, Neumayer L, Khuri S, Henderson W. Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care. Ann Surg. 2007;245(5):665-71. (Pubitemid 46684093)
17. Waljee JF, Hu ES, Newman LA, Alderman AK. Predictors of reexcision among women undergoing breast-conserving surgery for cancer. Ann Surg Oncol. 2008;15(5):1297-303.
18. McCahill LE, Single RM, Aiello Bowles EJ, Feigelson HS, James TA, Barney T, et al. Variability in reexcision following breast conservation surgery. JAMA. 2012;307(5):467-75.
19. Cellini C, Hollenbeck ST, Christos P, Martins D, Carson J, Kemper S, et al. Factors associated with residual breast cancer after re-excision for close or positive margins. Ann Surg Oncol. 2004;11(10):915-20. (Pubitemid 40486677)
20. Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg. 2005; 241(4):629-39. (Pubitemid 40397311)
21. Silverstein MJ. Ductal carcinoma in situ of the breast: controversial issues. Oncologist. 1998;3(2):94-103. (Pubitemid 28213171)
22. Menes TS, Tartter PI, Bleiweiss I, Godbold JH, Estabrook A, Smith SR. The consequence of multiple re-excisions to obtain clear lumpectomy margins in breast cancer patients. Ann Surg Oncol. 2005;12(11):881-5. (Pubitemid 41504220)
23. Azu M, Abrahamse P, Katz SJ, Jagsi R, Morrow M. What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates. Ann Surg Oncol. 2010;17(2):558-63.
24. Blair SL, Thompson K, Rococco J, Malcarne V, Beitsch PD, Ollila DW. Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons? J Am Coll Surg. 2009;209(5):608-13.
25. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection inwomenwith invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569-75.
26. Surgeons ASoB. 2012 Position statement on breast surgery quality measurement and initiative. https://www.breastsurgeons.org/statements/PDF- Statements/ASBS-POSITION-STATEMENT-ON-QUALITY-MEASUREMENT.pdf Accessed 01 Mar 2012.